Jiangsu Walvax Biotech News
Most Popular Jiangsu Walvax Biotech Story
GSK amasses $3.5B in flu vax orders
GlaxoSmithKline (GSK) is still toting up orders for its H1N1 vaccine. Since the company last updated its vaccine contract numbers in early August, it has garnered orders for an additional 149 million Read more...
Latest Headlines
- October 6, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
